袖状胃切除术术中肉毒杆菌毒素注射的初步随机对照试验
该前瞻性双盲随机对照试验在57例袖状胃切除术中评估术中幽门肉毒杆菌毒素注射(BP)的安全性和对术后恶心呕吐(PONV)的疗效。结果显示BP安全,但未改善围手术期结局或患者报告的PONV,与标准ERAS措施相比无差异。研究受疫情期间减重手术量减少的限制。
要点
- 术中幽门肉毒杆菌毒素注射在袖状胃切除术中是安全的。
- BP未减少止吐药使用或自报恶心,与安慰剂相当。
- BP未缩短手术时间或住院时间,也未增加并发症。
核心结论
- 袖状胃切除术中幽门肉毒杆菌毒素注射安全,但未改善围手术期结局或患者报告的PONV。
研究设计与样本
- 前瞻性、双盲随机对照试验,在大型三级医疗中心历时3年,纳入57例袖状胃切除术患者。
主要发现
- 手术时间BP组106.8分钟 vs 安慰剂组106.4分钟(p=0.94)。
- 住院时间BP组1.68天 vs 安慰剂组1.48天(p=0.40)。
- 无术中并发症,安慰剂组1例30天再入院(胸痛和脱水)。
- 门诊补液使用率BP组7.14% vs 安慰剂组6.90%(p>0.99)。
- 止吐药使用率BP组53.57% vs 安慰剂组58.62%(p=0.70),自报恶心BP组46.43% vs 安慰剂组51.72%(p=0.79)。
临床怎么用
- 不支持在袖状胃切除术中常规使用幽门肉毒杆菌毒素注射来改善PONV或围手术期结局。
局限性
- 疫情期间择期减重手术量减少导致样本量受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Botulinum toxin injection of the pylorus (BP) improves gastric transit after esophagectomy (Saeed et al. in Surg Endosc 38(10):6046-52, 2024). At our institution, BP has been used as an adjunct to sleeve gastrectomy (SG) to reduce post-operative nausea and vomiting (PONV). We studied the safety and efficacy of this practice. METHODS: A prospective, double-blinded randomized controlled trial of SG was performed with and without intraoperative BP at a large tertiary care medical center over a 3-year period was done. The primary outcome measured was safety of intraoperative BP during SG and followed by efficacy in treating PONV. RESULTS: We performed a prospective RCT on 57 SGs performed from 2019 to 2022. There were no differences in operative time (106.8 min BP vs. 106.4 min placebo, p = 0.94) and length of stay (1.68 days BP vs. 1.48 days placebo, p = 0.40). There were no intraoperative complications and one 30-day readmission for chest pain and dehydration in the placebo group. Utilization of outpatient hydration was equivalent (7.14% BP vs 6.90% placebo, p > 0.99). Anti-emetic usage (53.57% BP and 58.62% placebo, p = 0.70) and self-reported nausea (46.43% BP and 51.72% cohort, p = 0.79) were comparable. CONCLUSION: Intraoperative BP during SG is safe but does not improve peri-operative outcomes or patient-reported PONV when compared to standard ERAS measures. We were limited by reduction in elective bariatric case volume during the pandemic. Future study administering botulinum toxin preoperatively during endoscopy may be more successful.
引用
- Pradhan G, Robinson TD, Northrup C, et al. Intraoperative botulinum toxin injection in sleeve gastrectomy, a pilot randomized controlled trial. Surg Endosc. 2025. PMID: 40879776. doi:10.1007/s00464-025-12066-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。